Suppr超能文献

血液透析患者血清同型半胱氨酸水平与颈动脉内膜中层厚度的相关性。

Correlation Between Serum Homocysteine Levels and Carotid Intima-media Thickening in Hemodialysis Patients.

机构信息

Internal Medicine Department, Kashan University of Medical Sciences, Kashan, Iran.

出版信息

Iran J Kidney Dis. 2023 Jul;17(4):222-227.

Abstract

NTRODUCTION

Hyperhomocysteinemia is an important risk factor for cardiovascular disease in ESKD patients. Homocysteine, as an inflammatory factor, and carotid intima-media thickness (CIMT) could predict atherosclerosis in hemodialysis-treated ESKD patients. In this regard, the present study was conducted to investigate serum homocysteine level and its relationship with internal carotid intima thickness in ESKD patients undergoing routine hemodialysis.

METHODS

This study comprised 56 ESKD patients, older than 40 years, undergoing hemodialysis for at least 1 year. All participants were taking Nephrovit for at least 6 months. The study participants were patients who underwent ultrasonography for CIMT determination and laboratory test Results. There was no statistically significant relationship between the mean homocysteine level and hypertension, diabetes mellitus, duration of dialysis, and body mass index (BMI). Among the study participants, the results also showed that the mean value of CMIT homocysteine and C-reactive protein (CRP) were 0.89 millimeters, 30.44 (mcmol/L), and 35.60 mg/L; respectively. Despite hypertension, there was a significant difference between the mean values of CMIT in patients with diabetes mellitus and those who had been on dialysis for a longer period (more than 3 years). Also, the mean value of CMIT was significantly higher in obese patients than those with normal BMI. None of the other variables including homocysteine serum level, C-reactive protein (CRP), and CMIT showed a significant correlation.

CONCLUSION

The results of the study suggest that there is no relationship between serum homocysteine level and carotid intima-media thickness in hemodialysis patients.  DOI: 10.52547/ijkd.7424.

摘要

简介

高同型半胱氨酸血症是终末期肾病患者心血管疾病的一个重要危险因素。同型半胱氨酸作为一种炎症因子,与颈动脉内膜中层厚度(CIMT)可预测血液透析治疗的终末期肾病患者的动脉粥样硬化。在这方面,本研究旨在探讨血清同型半胱氨酸水平及其与常规血液透析的终末期肾病患者的颈内动脉内膜中层厚度的关系。

方法

本研究纳入 56 例年龄大于 40 岁、至少接受 1 年血液透析治疗的终末期肾病患者。所有患者均服用 Nephrovit 至少 6 个月。研究对象为接受 CIMT 测定和实验室检测结果的超声检查患者。同型半胱氨酸平均水平与高血压、糖尿病、透析时间和体重指数(BMI)之间无显著相关性。在研究对象中,CMIT 同型半胱氨酸和 C-反应蛋白(CRP)的平均值分别为 0.89 毫米、30.44(mcmol/L)和 35.60 毫克/升;分别。尽管患有高血压,但在患有糖尿病和透析时间较长(超过 3 年)的患者之间,CMIT 的平均值存在显著差异。此外,肥胖患者的 CMIT 平均值明显高于 BMI 正常的患者。包括血清同型半胱氨酸水平、C-反应蛋白(CRP)和 CMIT 在内的其他变量均无显著相关性。

结论

研究结果表明,血清同型半胱氨酸水平与血液透析患者的颈动脉内膜中层厚度之间无相关性。DOI:10.52547/ijkd.7424.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验